Filing Details
- Accession Number:
- 0001093557-16-000418
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-01-22 16:56:46
- Reporting Period:
- 2016-01-20
- Filing Date:
- 2016-01-22
- Accepted Time:
- 2016-01-22 16:56:46
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1093557 | Dexcom Inc | DXCM | Surgical & Medical Instruments & Apparatus (3841) | 330857544 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1286858 | R Kevin Sayer | 6340 Sequence Drive San Diego CA 92121 | President & Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2016-01-20 | 7,000 | $75.00 | 336,402 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- On December 14, 2015, Mr. Sayer adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Sayer. The shares set forth above were sold pursuant to the 10b5-1 Plan.
- Included in this number are 190,000 unvested restricted stock units, 90,000 of which were granted on March 8, 2015 and shall vest through March 8, 2018, 75,000 of which were granted on March 8, 2014 and shall vest through March 8, 2017, and 25,000 of which were granted on March 11, 2013 and shall vest through March 11, 2016.